The 40th Anniversary of Chinese Journal of Epidemiology
Epidemiological research in the big data era: opportunities, challenges and prospectives
Wang Yuzhuo, Ma Hongxia, Jin Guangfu, Hu Zhibin, Shen Hongbing
Published 2021-01-10
Cite as Chin J Epidemiol, 2021, 42(1): 10-14. DOI: 10.3760/cma.j.cn112338-20201203-01377
Abstract
Recent years with the rapid progress in high-throughput omics techniques, the accumulation of population cohorts and biobanks, great advances in internet and information technology, and the emerging tools for big data utilization, health care big data provide abundant data resources and broad research platforms for epidemiological research. We aimed to review the opportunities and challenges of epidemiological research in the era of big data, and explore the future development of epidemiology. Epidemiology should seize the opportunities, open up new directions, develop new methods, and promote the translation of research results into public health and clinical medicine, which will eventually realize the vision of "Healthy China".
Key words:
Health care big data; Epidemiological research; Systems epidemiology; Multidisciplinary integration
Contributor Information
Wang Yuzhuo
School of Public Health, Nanjing Medical University/Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
Ma Hongxia
School of Public Health, Nanjing Medical University/Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
Jin Guangfu
School of Public Health, Nanjing Medical University/Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
Hu Zhibin
School of Public Health, Nanjing Medical University/Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
Shen Hongbing
School of Public Health, Nanjing Medical University/Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China